Pluri Inc. financial data

Symbol
PLUR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Matam Advanced Technology Park, Building No. 5, Haifa, Israel
State of incorporation
NV
Fiscal year end
June 30
Former names
PLURISTEM THERAPEUTICS INC (to 7/13/2022), PLURISTEM LIFE SYSTEMS INC (to 12/28/2007), AI SOFTWARE INC (to 7/1/2003)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 651 % -22.7%
Return On Equity -632 % -320%
Return On Assets -57.1 % -11.1%
Operating Margin -3.68K % +63.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.47M shares -86.8%
Common Stock, Shares, Outstanding 5.51M shares -86.7%
Entity Public Float 22.9M USD -33.6%
Weighted Average Number of Shares Outstanding, Basic 5.46M shares +5.67%
Weighted Average Number of Shares Outstanding, Diluted 5.46M shares +5.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 598K USD +135%
Cost of Revenue 126K USD
Research and Development Expense 12.3M USD -13.3%
General and Administrative Expense 10.1M USD -12%
Operating Income (Loss) -22M USD +14.5%
Nonoperating Income (Expense) -303K USD +85%
Net Income (Loss) Attributable to Parent -21.8M USD +19.7%
Earnings Per Share, Basic -4.11 USD/shares +41.4%
Earnings Per Share, Diluted -4.11 USD/shares +41.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.2M USD -39.1%
Cash, Cash Equivalents, and Short-term Investments 26.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 3K USD -84.2%
Assets, Current 27M USD -23.3%
Property, Plant and Equipment, Net 846K USD +10.2%
Operating Lease, Right-of-Use Asset 6.4M USD -14.4%
Other Assets, Noncurrent 20K USD +186%
Assets 35.4M USD -20.4%
Employee-related Liabilities, Current 508K USD -18.6%
Accrued Liabilities, Current 1.1M USD +7.72%
Liabilities, Current 4.58M USD +6.04%
Operating Lease, Liability, Noncurrent 4.94M USD -9.06%
Retained Earnings (Accumulated Deficit) -426M USD -5.39%
Stockholders' Equity Attributable to Parent -5.28M USD -159%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -63K USD -101%
Liabilities and Equity 35.4M USD -20.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.06M USD +30.6%
Net Cash Provided by (Used in) Investing Activities 585K USD -89.9%
Common Stock, Shares Authorized 37.5M shares -87.5%
Common Stock, Shares, Issued 5.51M shares -86.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.46M USD -3462%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.22M USD -31.5%
Deferred Tax Assets, Valuation Allowance 73.8M USD -13%
Deferred Tax Assets, Gross 71.3M USD +11.5%
Operating Lease, Liability 5.59M USD -12.4%
Depreciation 65K USD -2.99%
Payments to Acquire Property, Plant, and Equipment 208K USD +102%
Lessee, Operating Lease, Liability, to be Paid 7.71M USD -14.1%
Property, Plant and Equipment, Gross 18.4M USD +1.4%
Operating Lease, Liability, Current 574K USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.01M USD -9.49%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.11M USD -4.46%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.12M USD -18.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 977K USD -3.84%
Deferred Tax Assets, Operating Loss Carryforwards 69.9M USD -13.3%
Preferred Stock, Shares Authorized 1M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.02M USD +3.02%
Operating Lease, Payments 14K USD
Additional Paid in Capital 421M USD +1.84%
Deferred Tax Assets, Net of Valuation Allowance 73.8M USD -13%
Share-based Payment Arrangement, Expense 170K USD -17.1%
Interest Expense 868K USD +0.46%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares